Legendary investor Warren Buffett’s advice to be fearful when others are greedy and greedy when others are fearful is being put to the test with the Relative Strength Index (RSI) indicator. ADMA Biologics Inc (ADMA) entered oversold territory with an RSI reading of 29.7, compared to the S&P 500 ETF (SPY) at 67.8. This may signal a buying opportunity as heavy selling could be running its course. ADMA’s 52-week range is $13.50 to $25.67, with the stock currently trading at $15.30. Other oversold stocks are also worth exploring for potential investment opportunities.

Read more at Nasdaq: Relative Strength Alert For ADMA Biologics